Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV004584566 | SCV002578107 | uncertain significance | See cases | 2021-12-15 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2 |
Labcorp Genetics |
RCV003097735 | SCV003265729 | uncertain significance | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1196 of the ADAMTS13 protein (p.His1196Gln). This variant is present in population databases (rs782230828, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ADAMTS13-related conditions. ClinVar contains an entry for this variant (Variation ID: 1708458). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect ADAMTS13 function (PMID: 27802307). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003138155 | SCV003822580 | uncertain significance | Upshaw-Schulman syndrome | 2019-11-04 | criteria provided, single submitter | clinical testing |